TriSalus Life Sciences, Inc.

NASDAQ:TLSI

Medical - Devices

Healthcare
$2.45 +0.49%

+$0.02 today

Market cap
$151.16M
Beta
0.49
P/E (TTM)
-7.4
EPS (TTM)
-$0.53
52W Low $2.20High $7.95

Volume 0.40M

Average 0.38M

TLSI Account Payables

Amounts the company owes suppliers for goods and services received.

TriSalus Life Sciences, Inc.NASDAQ: TLSI

Account Payables · Q1 FY2026 · quarter ended Mar 2026

Account payables rises 50.8% from a year ago

Account payables stood at $4.23M at the end of Q1 FY2026, up 50.8% from a year earlier and up 41.0% from the prior quarter. Over 3 fiscal years it compounded at -15.3% a year.

Context

  • Account payables amounted to 6.0% of total assets at the end of Q1 FY2026, down 3.8 pp from a year earlier.
  • Account payables increased in 1 of the last 3 fiscal years.

What to watch

Whether account payables keeps rising in the next quarterly balance sheet after a +50.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$4.23M+41.0% QoQ
Last fiscal yearDec 2025
$3M+32.0% YoY
Year agoMar 2025
$2.81M+50.8% since
Account Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+50.8%——
1 year+32.0%——
3-year CAGR-15.3%——
5-year CAGR——
10-year CAGR——

Account Payables history

USD · from the balance sheet

Latest · FY2025
3M USD
Year-over-year change
+32.0%
4-year CAGR
+23.3%

Account Payables vs competitors

How TLSI compares with its peers on the latest reported figures

  • TLSI's Mar 2026 account payables of $4.23M is the 5th highest of the 11 companies compared; the peer median is $3.34M.
  • Its year-over-year change of +50.8% is the 3rd highest of 11, against a peer median of +11.5%.
  • Account payables amounts to 6.0% of total assets for TLSI, versus a peer median of 2.3%.
TLSI Competitors Peer median
Account Payables for TLSI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CATXPerspective Therapeutics, Inc.Mar 2026$26.49M +203.2%+137.0%6.4%
OWLTOwlet, Inc.Mar 2026$11.78M -7.3%-26.7%13.6%
STIMNeuronetics, Inc.Mar 2026$11.43M +34.8%+64.0%9.1%
LNSRLENSAR, Inc.Mar 2026$10.1M +30.2%+51.8%15.2%
TLSITriSalus Life Sciences, Inc.Mar 2026$4.23M +50.8%-15.3%6.0%
AVRAnteris Technologies Global Corp.Mar 2026$3.79M -30.8%+85.9%1.3%
NNOXNano-X Imaging Ltd.Dec 2025$2.89M +30.6%-7.3%1.8%
PROFProfound Medical Corp.Mar 2026$2.15M +105.1%+1.7%2.9%
PREPrenetics Global LimitedMar 2026$1.96M -52.6%+1.9%1.1%
MXCTMaxCyte, Inc.Mar 2026$1.2M -47.5%+68.7%0.6%
ARMPArmata Pharmaceuticals, Inc.Mar 2026$660K -32.7%-46.6%0.9%
Peer median (excluding TLSI) $3.34M+11.5%+26.9%2.3%

Competitors are the stored peer set for TLSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents30.3M9.41M11.78M8.53M20.44M
Short-term Investments00000
Net Receivables1.36M1.56M3.55M5.09M6.56M
Inventory1.29M1.47M2.55M4.05M3.08M
Other Current Assets00000
Total Current Assets35.13M17.21M20.86M20.67M32.24M
Property, Plant & Equipment (Net)1.8M3.61M3.27M2.88M2.67M
Goodwill00000
Intangible Assets794K802K000
Long-term Investments0250K0350K400K
Tax Assets00000
Other Non-current Assets115K117K466K73K18K
Total Non-current Assets2.71M4.78M3.74M3.3M3.09M
Total Assets37.84M22M24.6M23.97M35.33M
Account Payables1.3M4.95M3.39M2.27M3M
Short-term Debt0370K00167K
Tax Payables00034K0
Deferred Revenue00000
Other Current Liabilities104K23.57M420K383K8.23M
Total Current Liabilities6.37M32.36M14.69M10.23M11.5M
Long-term Debt00022.08M34.27M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities561K369K35.73M16.22M23.42M
Total Non-current Liabilities561K1.96M36.98M39.64M57.69M
Total Liabilities6.93M34.32M51.66M49.87M69.19M
Common Stock11K02K3K4K
Retained Earnings(136.34M)(186.36M)(249.5M)(279.55M)(330.58M)
Accumulated OCI00(0)00
Other Stockholders Equity00000
Minority Interest00000
Total Equity30.9M(12.32M)(27.07M)(25.89M)(33.86M)
Total Debt01.96M1.6M23.63M34.44M
Net Debt(30.3M)(7.45M)(10.18M)15.1M14M

TriSalus Life Sciences, Inc.

NASDAQ:TLSI

Intrinsic Alpha fair value

Locked

Current Price

$2.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.